Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients [Phase 3]

View source ↗

Summary

This update reports the results of a Phase 3 trial comparing lomustine plus temozolomide versus standard therapy for glioblastoma to evaluate efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lomustine (Lomustine)
  • Temozolomide (Temozolomide)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED